Bremelanotide (10mg)

Bremelanotide, marketed under the brand name Vyleesi, is an FDA-approved medication indicated for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is characterized by a persistent absence of sexual desire or fantasies that results in significant personal distress or interpersonal challenges. (Same as PT-141).